CPG15 compounds as insulin receptor and insulin-like growth factor receptor agonists
US7884078B2 · kind B2 · utility
0Cited by
15References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 9, 2007 |
| Grant date | Feb 8, 2011 |
| Priority date | — |
| Expiry date | Feb 9, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are CPG15 and CPG15-2 compounds and inhibitors that act as agonists and antagonists of the insulin receptor and insulin-like growth factor receptors, and the use of such compositions for the treatment of insulin and insulin-like growth factor-related diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.